Azienda Socio Sanitaria Territoriale Dei Sette Laghi

At Azienda Socio Sanitaria Territoriale Dei Sette Laghi in Varese, clinical research in hematology focuses on cancers and disorders of the blood and bone marrow, including acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, and several forms of myelofibrosis. These studies are designed to test new treatment options, improve disease control, and better manage symptoms and complications.

• Acute leukemias and myelodysplastic syndromes are being studied to improve survival and treatment response.
• Chronic lymphocytic leukemia and related lymphoid cancers are being evaluated for deeper remission and better disease control.
• Multiple myeloma and myelofibrosis trials are exploring more effective and better-tolerated therapies.

Overall, this research area is centered on finding more precise and effective approaches for complex blood cancers and related marrow disorders.

The site also has a strong portfolio in oncology, with trials in non-small cell lung cancer, small cell lung cancer, breast cancer, ovarian cancer, colorectal cancer, and cervical carcinoma. Many of these studies aim to compare new anticancer therapies with current standards of care and to improve outcomes for patients with advanced or hard-to-treat disease.

• Lung cancer research includes both targeted and immunotherapy-based strategies.
• Breast, ovarian, and cervical cancer studies are evaluating ways to strengthen disease control after standard treatment.
• Colorectal cancer and mesothelioma research is examining better first-line and combination treatment approaches.

These trials reflect an active effort to expand treatment options for patients with advanced cancers across several tumor types.

Research in immune system diseases at this hospital includes studies on primary immune thrombocytopenia, autoimmune haemolytic anaemia, and other immune-mediated blood conditions. The main goal is to evaluate therapies that can better control abnormal immune activity and reduce disease-related complications.

• Autoimmune blood disorders are being studied for improved symptom control and blood count recovery.
• Immune-mediated anemia and thrombocytopenia trials are testing new ways to restore normal blood function.
• These studies aim to offer more targeted care for patients with difficult-to-manage immune disorders.

This area highlights the site’s interest in treatments that modulate the immune system more precisely and safely.

Clinical trials in cardiovascular diseases and related conditions address heart failure, hypertension, acute pulmonary embolism, and outcomes after major cardiac surgery. The research is aimed at improving prevention, reducing complications, and finding better treatment strategies for high-risk patients.

• Heart failure studies are evaluating whether new therapies can reduce hospital events and cardiovascular death.
• Pulmonary embolism research is focused on safer and more effective clot treatment.
• Cardiac surgery-associated kidney injury studies are exploring ways to protect patients during complex procedures.

These trials support better management of serious cardiovascular conditions where timely treatment can strongly influence outcomes.

The site conducts substantial research in respiratory tract diseases, especially lung cancer in multiple advanced forms and pleural mesothelioma. The purpose of these trials is to improve survival, refine treatment selection, and assess whether newer approaches can outperform existing standards.

• Advanced lung cancer studies are examining targeted therapy and immunotherapy combinations.
• Small cell lung cancer and non-small cell lung cancer trials are testing options for resistant or metastatic disease.
• Pleural mesothelioma research is exploring new strategies for a rare and aggressive cancer.

This therapeutic area is one of the site’s major strengths, with a clear focus on difficult thoracic cancers.

Research also extends to metabolism, type 2 diabetes, generalised lipodystrophy, and thyroid eye disease. These studies aim to improve disease control, reduce long-term complications, and test therapies that may address both symptoms and underlying disease mechanisms.

• Metabolic disease trials are assessing treatments for rare and complex disorders of fat distribution and glucose control.
• Type 2 diabetes studies are looking at strategies that may also benefit cardiovascular risk.
• Thyroid eye disease research is focused on improving eye symptoms and functional outcomes.

This mix of studies shows a broad interest in conditions that affect metabolism, endocrine health, and vision-related quality of life.

Additional trials at Azienda Socio Sanitaria Territoriale Dei Sette Laghi cover bacterial infections, female urogenital diseases, male urogenital diseases, eye diseases, otorhinolaryngologic diseases, and pathological conditions such as recurrent infection and precancerous oral disorders. The aim is to improve diagnosis, prevention, and treatment across a diverse set of clinical needs.

• Infectious disease research includes work on recurrent and difficult-to-treat infections.
• Oral potentially malignant disorders trials are examining ways to prevent cancer development.
• Urogenital and eye-related conditions are being studied to support better symptom management and patient care.

These studies add breadth to the site’s research portfolio and reflect its wide clinical expertise.